Literature DB >> 16648120

Complementary and alternative medicine (CAM) in Mexican patients with cancer.

Raquel Gerson-Cwilich1, Alberto Serrano-Olvera, Alberto Villalobos-Prieto.   

Abstract

BACKGROUND: Cancer is the second cause of death in Mexico, most cases are detected at advanced stages and the use of chemotherapy is frequent. At present, more than 300 types of complementary and/or alternative medicine (CAM) treatments are known that offer different therapeutic objectives. Many patients use this type of treatments.
OBJECTIVE: To determine the characteristics of the patients that use CAM, to identify the aim of these treatments, the source of information and the potential benefits obtained by the patient. PATIENTS AND METHODS: A questionnaire was applied from February 20 to March 5, 2004 to non-selected patients with cancer in private consultation to determine age, sex, education level, work, use of CAM, type and number of used therapies, potential benefits and monthly cost. Two groups were formed, A for users and B for non-users of CAM. Results between groups were compared and the mentioned variables were correlated with the use of alternative medicine.
RESULTS: Group A included 37 patients and group B included 38, with no difference regarding age, education level, work and oncological diagnosis, p > 0.05; a significant trend was found as regards the feminine sex, p = 0.07, neoplasm different from breast cancer, p = 0.08 and evident association with neoplasm advanced stages, p = 0.02. Most patients used between 1 and 3 types of therapies, 97.2%. The most common types of therapies were nutritional and spiritual, 54% and 48.6%, respectively. The source was the patient's family in 56.4% and the physician in 24.3%. Complementary and alternative therapy was considered a success in 57.1%; most of the users mentioned benefits (78.6%) deemed as tranquility (46.4%) or improvement of the physical condition (46.4%). The average monthly cost was $ 345.5 dollars, with a range of $ 13.6 to $ 2,545.5 dollars.
CONCLUSIONS: The use of complementary and/or alternative therapy is frequent among young women with advanced cancer and high level of education. The family participates in the decision of using these methods; most users noticed a benefit in their general condition and reported tranquility; these patients may be prone to higher incidence of depression and anxiety. The effectiveness and safety of this type of treatments remain to be determined, as well as the possible interactions with conventional therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16648120     DOI: 10.1007/s12094-006-0011-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  32 in total

1.  Why patients use alternative medicine: results of a national study.

Authors:  J A Astin
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

2.  Use of alternative medicine by women with early-stage breast cancer.

Authors:  H J Burstein; S Gelber; E Guadagnoli; J C Weeks
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

3.  Ethical considerations of complementary and alternative medical therapies in conventional medical settings.

Authors:  Karen E Adams; Michael H Cohen; David Eisenberg; Albert R Jonsen
Journal:  Ann Intern Med       Date:  2002-10-15       Impact factor: 25.391

4.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

5.  Advising patients who seek complementary and alternative medical therapies for cancer.

Authors:  Wendy A Weiger; Michael Smith; Heather Boon; Mary Ann Richardson; Ted J Kaptchuk; David M Eisenberg
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

6.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

7.  Evaluation of quality of life/life satisfaction in women with breast cancer in complementary and conventional care.

Authors:  Marianne Carlsson; Maria Arman; Marie Backman; Ursula Flatters; Thomas Hatschek; Elisabeth Hamrin
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

8.  Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.

Authors:  Heather Boon; Kathleen Westlake; Moira Stewart; Ross Gray; Neil Fleshner; Alan Gavin; Judith Belle Brown; Vivek Goel
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

9.  Use of complementary and alternative medicine among Korean cancer patients.

Authors:  Min Jae Kim; Sang Dae Lee; Duck Ryung Kim; Yun Ho Kong; Wee Sik Sohn; Seung Seog Ki; Jin Kim; Yu Cheol Kim; Chul Ju Han; Jin Oh Lee; Hyeon-Seok Nam; Yeon-Hee Park; Cheol Hyeon Kim; Ka-Hee Yi; Yoon Yong Lee; Sook-Hyang Jeong
Journal:  Korean J Intern Med       Date:  2004-12       Impact factor: 2.884

10.  Health food store recommendations: implications for breast cancer patients.

Authors:  Edward Mills; Edzard Ernst; Rana Singh; Cory Ross; Kumanan Wilson
Journal:  Breast Cancer Res       Date:  2003-08-06       Impact factor: 6.466

View more
  11 in total

1.  Biologically based therapies are commonly self-prescribed by Brazilian women for the treatment of advanced breast cancer or its symptoms.

Authors:  Ana Camila Callado Alfano; Carlos Eduardo Paiva; Fernanda Capella Rugno; Raquel Haas da Silva; Bianca Sakamoto Ribeiro Paiva
Journal:  Support Care Cancer       Date:  2013-12-17       Impact factor: 3.603

2.  In vitro screening of tumoricidal properties of international medicinal herbs: part II.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Phytother Res       Date:  2010-12       Impact factor: 5.878

Review 3.  Cancer and Traditional Plant Knowledge, an Interesting Field to Explore: Data from the Catalan Linguistic Area.

Authors:  Airy Gras; Montse Parada; Jaume Pellicer; Joan Vallès; Teresa Garnatje
Journal:  Molecules       Date:  2022-06-24       Impact factor: 4.927

4.  In vitro screening for the tumoricidal properties of international medicinal herbs.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Phytother Res       Date:  2009-03       Impact factor: 5.878

5.  Cytotoxic effect of the ethanolic extract of Lophocereus schottii: a Mexican medicinal plant.

Authors:  Arturo Orozco-Barocio; Brenda Lizbeth Paniagua-Domínguez; Pedro Alberto Benítez-Saldaña; Edgardo Flores-Torales; Salvador Velázquez-Magaña; Hilda Julieta Arreola Nava
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-04-12

6.  Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial.

Authors:  I L G Farias; M C S Araújo; J G Farias; L V Rossato; L I Elsenbach; S L Dalmora; N M P Flores; M Durigon; I B M Cruz; V M Morsch; M R C Schetinger
Journal:  Evid Based Complement Alternat Med       Date:  2011-08-21       Impact factor: 2.629

7.  Evaluating medicinal plants for anticancer activity.

Authors:  Elisha Solowey; Michal Lichtenstein; Sarah Sallon; Helena Paavilainen; Elaine Solowey; Haya Lorberboum-Galski
Journal:  ScientificWorldJournal       Date:  2014-11-13

8.  The use of rehabilitation among patients with breast cancer: a retrospective longitudinal cohort study.

Authors:  Yi-Hsien Lin; Po-Jung Pan
Journal:  BMC Health Serv Res       Date:  2012-08-28       Impact factor: 2.655

9.  Appraisals of Bangladeshi Medicinal Plants Used by Folk Medicine Practitioners in the Prevention and Management of Malignant Neoplastic Diseases.

Authors:  Md Nur Kabidul Azam; Md Mizanur Rahman; Samanta Biswas; Md Nasir Ahmed
Journal:  Int Sch Res Notices       Date:  2016-01-14

10.  Isolation and Cytotoxic Activity of Phyllocladanes from the Roots of Acacia schaffneri (Leguminosae).

Authors:  José de Jesús Manríquez-Torres; Marco Antonio Hernández-Lepe; José Román Chávez-Méndez; Susana González-Reyes; Idanya Rubí Serafín-Higuera; Genaro Rodríguez-Uribe; Jesús Martín Torres-Valencia
Journal:  Molecules       Date:  2020-08-28       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.